摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(1S,4S)-5-甲基-2,5-二氮杂双环[2.2.1]庚烷-2-羧酸叔丁酯 | 244768-98-7

中文名称
(1S,4S)-5-甲基-2,5-二氮杂双环[2.2.1]庚烷-2-羧酸叔丁酯
中文别名
——
英文名称
tert-Butyl 5-methyl-2,5-diaza-bicyclo[2.2.1]heptane-2-carboxylate
英文别名
tert-butyl 5-methyl-2,5-diazabicyclo[2.2.1]heptane-2-carboxylate
(1S,4S)-5-甲基-2,5-二氮杂双环[2.2.1]庚烷-2-羧酸叔丁酯化学式
CAS
244768-98-7
化学式
C11H20N2O2
mdl
——
分子量
212.29
InChiKey
VYYZBKDBMOBMBG-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    272℃
  • 密度:
    1.091
  • 闪点:
    118℃

计算性质

  • 辛醇/水分配系数(LogP):
    1.2
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.91
  • 拓扑面积:
    32.8
  • 氢给体数:
    0
  • 氢受体数:
    3

文献信息

  • [EN] NAMPT MODULATORS<br/>[FR] MODULATEURS DE NAMPT
    申请人:CYTOKINETICS INC
    公开号:WO2021159015A1
    公开(公告)日:2021-08-12
    Provided are compounds of Formula (II) or a pharmaceutically acceptable salt thereof, wherein R1, R2, R3, R4, R5, R6, and p are as defined herein. Also provided is a pharmaceutically acceptable composition comprising a compound of Formula (II), or a pharmaceutically acceptable salt thereof. Also provided are methods of using a compound of Formula (II), or a pharmaceutically acceptable salt thereof.
    提供了公式(II)的化合物或其药用可接受盐,其中R1、R2、R3、R4、R5、R6和p如本文所定义。还提供了包含公式(II)化合物或其药用可接受盐的药用可接受组合物。还提供了使用公式(II)化合物或其药用可接受盐的方法。
  • COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY
    申请人:Li Hui
    公开号:US20100190770A1
    公开(公告)日:2010-07-29
    Disclosed are compounds of formula I, compositions containing them, and methods of use for the compounds and compositions in the treatment of conditions in which modulation of the JAK pathway or inhibition of JAK kinases, particularly JAK 2 and JAK3, are therapeutically useful.
    公开了化合物I的结构,含有这些化合物的组合物,以及在治疗需要调节JAK途径或抑制JAK激酶,特别是JAK 2和JAK3的情况下使用这些化合物和组合物的方法。
  • METHODS FOR HAIR FOLLICLE STEM CELL PROLIFERATION
    申请人:Frequency Therapeutics, Inc.
    公开号:US20200121681A1
    公开(公告)日:2020-04-23
    The present invention relates to compositions of minoxidil and Sonic Hedgehog (Shh) pathway activators and optionally, Wnt agonists and methods of using them to induce self-renewal of hair follicle stem cells, including inducing the hair follicle stem cells to proliferate while maintaining, in the daughter cells, the capacity to differentiate into hair follicle epithelial cells.
    本发明涉及米诺地尔和Sonic Hedgehog (Shh)途径激活剂以及可选的Wnt激动剂的组合物,以及使用它们诱导毛囊干细胞的自我更新的方法,包括诱导毛囊干细胞增殖,同时保持子细胞具有分化为毛囊上皮细胞的能力。
  • Organic Compounds
    申请人:Fairhurst Robin Alec
    公开号:US20090240045A1
    公开(公告)日:2009-09-24
    A compound of formula (I) or stereoisomers or pharmaceutically acceptable salts thereof, and their preparation and use as pharmaceuticals wherein R 1 , R 2 , R 3 , R 4 and W are as defined herein.
    式(I)的化合物,或其立体异构体或药学上可接受的盐,以及它们的制备和用作药物,其中R1、R2、R3、R4和W的定义如本文所述。
  • Chemokine receptor modulators
    申请人:Clark Michael P.
    公开号:US20080261978A1
    公开(公告)日:2008-10-23
    The invention provides compounds of Formula (I) and pharmaceutical compositions comprising compounds of Formula (I). These compounds are useful treating or preventing HIV infections, and in treating proliferative disorders such as inhibiting the metastasis of various cancers
    该发明提供了式(I)的化合物及包含该化合物的药物组合物。这些化合物可用于治疗或预防HIV感染,并用于治疗增殖性疾病,如抑制各种癌症的转移。
查看更多